| Dr Chris Frederick, MD | |
|
U.s. Naval Hospital Guam, Bldg 50 Farenholt Avenue, Agana Heights, GU 96910 | |
| (671) 344-9340 | |
| Not Available |
| Full Name | Dr Chris Frederick |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | U.s. Naval Hospital Guam, Agana Heights, Guam |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639661978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 01082591A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chris Frederick, MD U.s. Naval Hospital Guam, Psc 455 Box 208, Fpo, AP 96540 Ph: (671) 344-9340 | Dr Chris Frederick, MD U.s. Naval Hospital Guam, Bldg 50 Farenholt Avenue, Agana Heights, GU 96910 Ph: (671) 344-9340 |
News Archive
TheraSim, Inc., the leading simulation-training company dedicated to providing online tools and solutions to reduce performance errors in healthcare and clinical research, secured a $1.25 million round of investment from UK-based Andromeda Capital.
Children who have neurological disorders such as cerebral palsy or epilepsy are no more likely to be vaccinated against influenza than youngsters without these conditions, despite the increased risk for complications from flu these children experience.
The advent of nanotechnology on the modern landscape has dramatically changed the shape, size, quality, cost, and efficiency of various applications. Nanotechnology is believed to be the most path-breaking technology, with this market expected to reach $1 trillion by 2015. The remarkable properties of the various nanomaterials have caught the attention of scientists, researchers, and manufacturers alike, and ongoing research activities are underway to harness their potential for the overall betterment of society.
Dr. Bruce Bode announced today that he is now recruiting adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes.
The American Association of Occupational Health Nurses (AAOHN) and the American College of Occupational and Environmental Medicine (ACOEM) have announced they will collaborate to study workplace health and safety issues associated with worker impairment from the use of marijuana and other drugs.
› Verified 4 days ago
Dr. Thomas C Baugh, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: U.s. Naval Hospital Guam, Farenholt Street, Building K-1, Agana Heights, GU 96919 Phone: 671-344-9232 | |
Dr. Christopher Boyd Chisholm, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Us Naval Hospital Guam, Farenholt Ave Bld K1, Agana Heights, GU 96919 Phone: 671-344-9619 | |
Dr. John T Haggerty, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: Bldg 50, Farenholt Ave, Agana Heights, GU 96910 Phone: 671-344-9340 | |
Jessica Arrott, Emergency Medicine Medicare: Medicare Enrolled Practice Location: Bldg 50, Farenholt Ave, Agana Heights, GU 96910 Phone: 671-344-9340 |